DOSE SELECTION FOR ANTI-INFECTIVE DRUGS: INDUSTRY PERSPECTIVE Dennis M. Grasela, PharmD, PhD Executive Director, Infectious Diseases Department of Clinical Discovery Bristol-Myers…
